Sherry McKee
Director, Yale Behavioral Pharmacology Laboratory · Yale-New Haven Hospital
Credentials: · ·
History
- Present
Yale Behavioral Pharmacology Laboratory · Yale-New Haven Hospital
- Present
Forensic Drug Diversion Clinic · Yale-New Haven Hospital
- Present
Yale SCORE Program for Sex Differences in Alcohol Use Disorder · Yale-New Haven Hospital
Research
Sex differences in stress-related alcohol use
Review · Neurobiology of Stress · 2019 · Last of 7 authors · Corresponding · 347 citations
Sex/gender differences in smoking cessation: A review
Review · Preventive Medicine · 2016 · Last of 5 authors · 347 citations
Smoking and mental illness in the U.S. population
Tobacco Control · 2014 · Last of 3 authors · 252 citations
- CM
38 papers
- LO
20 papers
- CB
16 papers
- BT
15 papers
- JS
11 papers
- IP
10 papers
8 papers
6 papers
Grants
- 2020–2030
Yale-SCORE on Sex Differences in Alcohol Use Disorder
National Institute on Alcohol Abuse and Alcoholism · U54
Contact PI · $11.5M · Yale University
- 2024–2029
National Institute on Alcohol Abuse and Alcoholism · R01
Contact PI · $2.1M · Yale University
- 2025–2028
Multi Site Randomized Trial of a GLP-1/GIP Receptor Agonist for Smoking Cessation
National Institute on Drug Abuse · U01
PI · $5.7M · University of Southern California
- 2024–2027
National Institute on Alcohol Abuse and Alcoholism · R34
Contact PI · $732.8K · Yale University
Clinical trials
- 2026–2030
Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder
Principal investigator · Recruiting · Phase 2
Yale University
- 2024–2026
Developing a Novel Human Laboratory Paradigm for AUD Medication Screening
Principal investigator · Recruiting
Yale University
- 2024–2026
Apremilast for Alcohol Use Disorder Treatment in Women and Men
Principal investigator · Active not recruiting · Phase 1
Yale University
- 2020–2025
Combining Varenicline and Guanfacine for Smoking Cessation
Principal investigator · Completed · Phase 2
Yale University